Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens
AssigneeEdge Animal Health, Inc.
InventorsKristi Mae MOORE, Michelle Lynn HAVEN, Richard E. PETERSON
Life of this patent
Estimating the term…
Loading patent…
AssigneeEdge Animal Health, Inc.
InventorsKristi Mae MOORE, Michelle Lynn HAVEN, Richard E. PETERSON
Estimating the term…
The present invention provides compositions and methods for immunizing a subject in need thereof again an avian pathogen. In one aspect, the invention provides a composition for immunizing an avian subject against a pathogen comprising: a) a recombinant laryngotracheitis virus vector (rLT); and b) a fusion gene of an avian virus (F) inserted into the recombinant laryngotracheitis virus vector (rLT/F); wherein the recombinant laryngotracheitis virus vector inserted with the fusion gene of the avian virus (rLT/F) is deoptimized to generate deoptimized rLT/F vaccine candidates; and wherein the deoptimized rLT/F vaccine candidates are administered to the subject in need thereof.
A composition for immunizing an avian subject against a pathogen comprising:
The deoptimized rLT/F vaccine according to 6, wherein the avian virus is selected from Newcastle disease virus (NDV), infectious bronchitis virus (IBV), infectious laryngotracheitis virus (ILTV) or avian influenza (AI).
Dependencies are inferred from the claim text.